Seven-Step Continuous Flow Synthesis of Linezolid Without Intermediate Purification

Area of Science:

• Organic Chemistry
• Chemical Engineering
• Pharmaceutical Synthesis

Background:

• Linezolid is a crucial antibiotic for treating serious infections caused by Gram-positive bacteria.
• Traditional synthesis of linezolid can be complex and time-consuming.
• Continuous flow chemistry offers potential advantages in efficiency and scalability for drug manufacturing.

Purpose of the Study:

• To develop a novel, highly efficient continuous flow synthesis of linezolid.
• To establish a new record for the number of distinct chemical transformations performed in a continuous flow sequence without intermediate purification or solvent exchange.
• To demonstrate the feasibility of producing linezolid using a streamlined, scalable flow chemistry approach.

Main Methods:

• A convergent continuous flow sequence was designed to synthesize linezolid from simple starting materials.
• Seven distinct chemical transformations were integrated into a single, uninterrupted flow process.
• The synthesis was optimized to minimize residence time and maximize throughput.

Main Results:

• Linezolid was successfully synthesized with a 73% isolated yield.
• The synthesis involved seven sequential chemical transformations, a record for continuous flow without intermediate steps.
• The process achieved a high throughput of 816 mg/h within a total residence time of 27 minutes.

Conclusions:

• This study presents a highly efficient and streamlined continuous flow synthesis of the important antibacterial drug linezolid.
• The developed method sets a new benchmark for multi-step synthesis in continuous flow, showcasing its potential for pharmaceutical production.
• The approach offers a scalable and rapid route to linezolid, potentially improving accessibility and reducing manufacturing costs.